Inhibition of PI3K by LY294002 or other PI3K inhibitors and mTOR by rapamycin have been demonstrated to induce G1 cell cycle arrest in the prostate cancer cells [37] and other human malignances [38, 39]. The gene discussed is MTOR; the disease is Familial prostate cancer.